Initiative for Patient Outcomes in Dialysis - Peritoneal Dialysis (PD) (IPOD-PD Study)
IPOD-PD
1 other identifier
observational
1,092
27 countries
131
Brief Summary
The aim of the study is to asses the hydration status of incident peritoneal dialysis (PD) patients and its evolution over a period of four years, independent of the PD treatment modality (APD or CAPD) and the PD solution type.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2011
Longer than P75 for all trials
131 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedFirst Submitted
Initial submission to the registry
January 26, 2011
CompletedFirst Posted
Study publicly available on registry
January 28, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedMay 2, 2016
April 1, 2016
4.9 years
January 26, 2011
April 29, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hydration status
Assessed via body composition measurements (Overhydration, total body water (TBW), extracellular water (ECW), intracellular water (ICW)) (Overhydration, total body water (TBW), extracellular water (ECW), intracellular water (ICW))
Every three months over a period of four years
Secondary Outcomes (4)
Residual renal function
Every three months over a period of four years
Peritoneal transport status
Every three months over a period of four years
Time to change to haemodialysis
Four years
Changes in PD prescription
Four years
Interventions
This is a purely non-interventional, observational study, where treatment decisions are completely guided by the discretion of the attending nephrologists.
Eligibility Criteria
Adult patients with chronic kidney disease (CKD) starting renal replacement therapy on APD or CAPD
You may qualify if:
- Incident patients directly before start of peritoneal dialysis
- Patients in whom routine measurement of body composition monitoring is performed
You may not qualify if:
- Patients treated with HD before start of PD
- Patients in whom body composition monitoring cannot be performed
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (134)
Klinikum Wels
Wels, Austria
ASZ Aalst
Aalst, Belgium
ASZ Geraardsbergen
Geraardsbergen, Belgium
Ghent University Hospital
Ghent, Belgium
U.Z. Leuven
Leuven, Belgium
CHU Sart Tilman
Liège, Belgium
Heilig-Hart Roeselare
Roeselare, Belgium
KBC Mostar
Mostar, Bosnia and Herzegovina
UKC Tuzla
Tuzla, Bosnia and Herzegovina
Instituto Mineiro Nefrologia
Belo Horizonte, Brazil
CDR Barra do Piraí
Piraí, Brazil
CETENE
São Paulo, Brazil
UHC Osijek
Osijek, Croatia
UH Split
Split, Croatia
UH Merkur
Zagreb, Croatia
Instituto de Nefrología
La Habana, Cuba
University Hospital FN Brno Bohunice
Brno, Czechia
FN Hradec Kralove
Hradec Králové, Czechia
DS Most
Most, Czechia
Faculty Hospital Plzen
Pilsen, Czechia
IKEM
Prague, Czechia
VFN Strahov
Prague, Czechia
Třebíč Hospital
Třebíč, Czechia
Herlev Hospital
Herlev, Denmark
Hillerød Hospital
Hillerød, Denmark
Roskilde Hospital
Roskilde, Denmark
North Estonian Regional Hospital
Tallinn, Estonia
West Talinn Central Hospital
Tallinn, Estonia
Tartu University Hospital
Tartu, Estonia
Helsinki University Hospital
Helsinki, Finland
Central Hospital in Joensuu
Joensuu, Finland
Keski-Suomen keskussairaala, Jyväskylä
Jyväskylä, Finland
Kymenlaakson keskussairaala, Kotka
Kotka, Finland
Oulu University Hospital
Oys, Finland
Satakunnan keskussairaala, Pori
Pori, Finland
Tampere University Hospital
Tampere, Finland
CHU de Bordeaux
Bordeaux, France
C.H. Dunkerque
Dunkirk, France
Hôpital Bichat - Claude Bernard
Paris, France
Centre Hospitalier René Dubos
Pontoise, France
AUB Quimper / Centre Hospitalier Laennec
Quimper, France
ECHO Confluent
Rezé, France
Hôpital Civil de Strasbourg
Strasbourg, France
KfH Nierenzentrum Bottrop
Bottrop, Germany
Klinikum Braunschweig
Braunschweig, Germany
Nierenzentrum Heidelberg
Heidelberg, Germany
Nieren und Hochdruckzentrum Kiel
Kiel, Germany
Robert Bosch Krankenhaus
Stuttgart, Germany
Nephrologisches Zentrum Velbert Innere Medizin und Nephrologie
Velbert, Germany
Nephrologische Praxis Wiesbaden
Wiesbaden, Germany
General University Hospital of Alexandroupolis
Alexandroupoli, Greece
General Hospital of Athens G. Gennimatas
Athens, Greece
General Hospital of Ioannina
Ioannina, Greece
General University Hospital of Ioannina
Ioannina, Greece
General University Hospital of Thessaloniki "AHEPA"
Thessaloniki, Greece
MMM - Chennai
Chennai, India
Western Galilee Hospital
Nahariya, Israel
UO Nefrologia Policlinico BARI
Bari, Italy
Azienda Ospedaliera Brotzu
Cagliari, Italy
Ospedale Civico Palermo
Palermo, Italy
Ospedale San Bartolo
Vicenza, Italy
Med Alfa Ltda
Riga, Latvia
P. Stradins hospital
Riga, Latvia
Kaunas clinics
Kaunas, Lithuania
Klaipeda Republic Hospital
Klaipėda, Lithuania
Vilnius Univ. Antakalnio Hospital
Vilnius, Lithuania
University Hospital Maastricht
Maastricht, Netherlands
Sykehuset i Møre og Romsdal HF
Ålesund, Norway
Nordlandssykehuset Bodø
Bodø, Norway
Sykehuset Levanger
Levanger, Norway
St. Olavs Hospital
Sluppen, Norway
Hospital Santa Cruz
Carnaxide, Portugal
CHP Hospital Santo Antonio
Porto, Portugal
Yeungnam University Hospital
Daegu, South Korea
NHIC Ilsan Hospital
Goyang, South Korea
Konkuk University Medical Center
Seoul, South Korea
Seoul National University Hospitall
Seoul, South Korea
Severance Hospital
Seoul, South Korea
Hospital Universitario A Coruñ
A Coruña, Spain
CHU Albacete
Albacete, Spain
Hosp. Univ. Fundacion Alcorcon
Alcorcón, Spain
Hospital De Torrecardenas
Almería, Spain
Fundació Puigvert
Barcelona, Spain
Hospital Clínic de Barcelona
Barcelona, Spain
Hospital de Basurto
Bilbao, Spain
Hospital de Galdakano
Bilbao, Spain
Hospital Univ. Puerta del Mar
Cadiz, Spain
Hospital General de Castellón
Castellon, Spain
Hospital Josep Trueta
Girona, Spain
Complejo Hospitalario de Jaén
Jaén, Spain
CAULE
León, Spain
Hospital San Pedro
Logroño, Spain
Hospital Lucus Augusti
Lugo, Spain
Fundación Jiménez Díaz
Madrid, Spain
HGU Gregorio Marañon
Madrid, Spain
Hospital Clinico San Carlos
Madrid, Spain
Hospital Severo Ochoa
Madrid, Spain
Hospital Univ. Ramón y Cajal
Madrid, Spain
Hospital Universitario Puerta
Madrid, Spain
Fundación Hospital Manacor
Manacor, Spain
Hospital Carlos Haya
Málaga, Spain
Hospital de Mollet
Mollet del Vallès, Spain
Hospital Universitario Central
Oviedo, Spain
Hospital Univ. de Puerto Real
Puerto Real, Spain
HUM Valdecilla
Santander, Spain
CHUS
Santiago de Compostela, Spain
Hospital Virgen de la Macarena
Seville, Spain
Hospital Clínico de Valencia
Valencia, Spain
Hospital Rio Hortega
Valladolid, Spain
Hospital general de Vic
Vic, Spain
CHU Xeral Cies Vigo
Vigo, Spain
Hospital Txagorritxu
Vitoria-Gasteiz, Spain
Mälarsjukhuset Eskilstuna
Eskilstuna, Sweden
Sahlgrenska PD-mottagningen
Gothenburg, Sweden
Hallands Hospital Halmstad
Halmstad, Sweden
Sunderby Sjukhus
Luleå, Sweden
Skånes Universitetssjukhus Malmo
Malmo, Sweden
Danderyds Hospital
Stockholm, Sweden
Karolinska Univers. Hospital
Stockholm, Sweden
Kungsholmsdialysen
Stockholm, Sweden
Luzern Kantonsspital
Lucerne, Switzerland
Akdeniz Universitesi
Antalya, Turkey (Türkiye)
Western Infirmary Glasgow
Glasgow, United Kingdom
Royal London Hospital
London, United Kingdom
FME Caracas
Caracas, Venezuela
FME Charallave
Charallave, Venezuela
Cenesuca (FME Cumana)
Cumaná, Venezuela
FMC El tigre Edo Anzoátegui
El Tigre, Venezuela
FME Zulia
Maracaibo, Venezuela
FME Maturin
Maturín, Venezuela
FME Puerto de la Cruz
Puerto Cruz, Venezuela
FME Maracay
Turmero, Venezuela
Instituto Docente de Urologia
Valencia, Venezuela
Nefrologico Valencia sur
Valencia, Venezuela
Related Publications (2)
Verger C, Ronco C, Van Biesen W, Heaf J, Vrtovsnik F, Vera Rivera M, Puide I, Azar R, Gauly A, Atiye S, De Los Rios T. Association of Prescription With Body Composition and Patient Outcomes in Incident Peritoneal Dialysis Patients. Front Med (Lausanne). 2021 Dec 24;8:737165. doi: 10.3389/fmed.2021.737165. eCollection 2021.
PMID: 35004718DERIVEDRonco C, Verger C, Crepaldi C, Pham J, De Los Rios T, Gauly A, Wabel P, Van Biesen W; IPOD-PD Study Group. Baseline hydration status in incident peritoneal dialysis patients: the initiative of patient outcomes in dialysis (IPOD-PD study)dagger. Nephrol Dial Transplant. 2015 May;30(5):849-58. doi: 10.1093/ndt/gfv013. Epub 2015 Mar 11.
PMID: 25762355DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Claudio Ronco, Prof
Ospedale San Bartolo
- STUDY CHAIR
Wim Van Biesen, Prof
University Hospital, Ghent
- STUDY CHAIR
Christian Verger, Dr
French Language PD Registry (RDPLF)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 26, 2011
First Posted
January 28, 2011
Study Start
January 1, 2011
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
May 2, 2016
Record last verified: 2016-04